Table 1. Fisher's exact test: clinicopathological features and PATZ1 expression.
| Variables | PATZ1 expression | |||
|---|---|---|---|---|
| GBM | n. | +/++/+++ | - | p |
| Age | 45 | |||
| <60 | 11 | 10 (91%) | 1 (9%) | 0.0695 |
| ≥60 | 34 | 21 (62%) | 13 (38%) | |
| Gender | 45 | |||
| Males | 30 | 27 (90%) | 3 (10%) | 0.0028 |
| Females | 15 | 7 (47%) | 8 (53%) | |
| Site | 42 | |||
| Temporal | 22 | 14 (64%) | 8 (36%) | 0.5586 |
| Parietal | 11 | 9 (82%) | 2 (18%) | |
| Frontal | 9 | 6 (67%) | 3 (33%) | |
| Oligodendrogliomas | ||||
| Age | 22 | |||
| <60 | 17 | 9 (53%) | 8 (47%) | 0.7805 |
| ≥60 | 5 | 3 (60%) | 2 (40%) | |
| Gender | 22 | |||
| Males | 15 | 9 (60%) | 6 (40%) | 0.4520 |
| Females | 7 | 3 (43%) | 4 (57%) | |
| Site | 21 | |||
| Frontal | 14 | 6 (43%) | 8 (57%) | 0.1974 |
| Temporal | 4 | 2 (50%) | 2 (50%) | |
| Occipital | 3 | 3 (100%) | 0 (0%) | |
| Grading | 22 | |||
| II | 12 | 4 (33%) | 8 (67%) | 0.0286 |
| III | 10 | 8 (80%) | 2 (20%) |